- Home
- SGMT vs AFBI Comparison
SGMT vs AFBI Comparison
Compare SGMT & AFBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- AFBI
- Stock Information
- Founded
- SGMT 2006
- AFBI 1928
- Country
- SGMT United States
- AFBI United States
- Employees
- SGMT N/A
- AFBI N/A
- Industry
- SGMT
- AFBI Major Banks
- Sector
- SGMT
- AFBI Finance
- Exchange
- SGMT Nasdaq
- AFBI Nasdaq
- Market Cap
- SGMT 128.5M
- AFBI 113.6M
- IPO Year
- SGMT 2023
- AFBI N/A
- Fundamental
- Price
- SGMT $3.72
- AFBI $17.75
- Analyst Decision
- SGMT Strong Buy
- AFBI
- Analyst Count
- SGMT 6
- AFBI 0
- Target Price
- SGMT $25.67
- AFBI N/A
- AVG Volume (30 Days)
- SGMT 315.0K
- AFBI 25.4K
- Earning Date
- SGMT 03-12-2025
- AFBI 04-25-2025
- Dividend Yield
- SGMT N/A
- AFBI 8.45%
- EPS Growth
- SGMT N/A
- AFBI N/A
- EPS
- SGMT N/A
- AFBI 0.83
- Revenue
- SGMT N/A
- AFBI $30,608,000.00
- Revenue This Year
- SGMT N/A
- AFBI N/A
- Revenue Next Year
- SGMT N/A
- AFBI N/A
- P/E Ratio
- SGMT N/A
- AFBI $21.39
- Revenue Growth
- SGMT N/A
- AFBI 3.04
- 52 Week Low
- SGMT $2.39
- AFBI $14.93
- 52 Week High
- SGMT $7.38
- AFBI $22.50
- Technical
- Relative Strength Index (RSI)
- SGMT 44.81
- AFBI 39.12
- Support Level
- SGMT $3.70
- AFBI $17.62
- Resistance Level
- SGMT $4.24
- AFBI $18.00
- Average True Range (ATR)
- SGMT 0.23
- AFBI 0.48
- MACD
- SGMT 0.04
- AFBI -0.08
- Stochastic Oscillator
- SGMT 45.70
- AFBI 18.81
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, and residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.